GAVI Alliance

UPS Horizons Newsletter | Accelerating Sustainable Solutions

Sustainability Insights and Updates | Fall 2020
Summary: 

Accelerating Sustainable Solutions

By Suzanne Lindsay-Walker

UPS Chief Sustainability Officer

Newsletter

Accelerating Sustainable Solutions

By Suzanne Lindsay-Walker

UPS Chief Sustainability Officer

UPS Infographic | Drone Deliveries Take Flight

We’re making history with UPS Flight Forward,™ one of the first drone airlines certified by the Federal Aviation Administration (FAA).
Multimedia with summary

This infographic is from UPS's latest Interactive Sustainability Report: Accelerating Sustainable Solutions. Visit ups.com/sustainability to see the Highlights brochure with translations, GRI Content Index, and other stories of innovation.

Innovating to Deliver Our Most Critical Shipments

Multimedia with summary

Healthcare and life science shipments come with unique demands. Temperatures are precisely controlled. Conditions must be continuously monitored. And when lives are affected, delays are not an option.

Better meeting the needs of the healthcare and life sciences industries is one of UPS’s strategic priorities, and we are rapidly improving our technology and capabilities in this space, including the delivery of shipments to remote areas. 

GSK CEO and GAVI Alliance CEO Discuss “The Other Six Billon” Live at Fortune Brainstorm Health Conference

Innovations in medicine and medical technology are designed to serve the 600 million people living in the most developed countries, and that’s who they typically benefit. But what about the other 6 billion?
Multimedia with summary

On Wednesday, November 2nd, Andrew Witty, GSK CEO, will join Seth Berkley, GAVI Alliance CEO, at Fortune Brainstorm Health for a discussion on “The Other Six Billion” referring to the areas of the world that are traditionally not served by innovations in medicine and medical technology. Outside of the most developed countries infectious diseases—including malaria, tuberculosis and HIV—still kill an astounding 15 million people a year.

GSK Enters New Commitment with the GAVI Alliance to Supply Cervical Cancer Vaccine for Girls in the World’s Poorest Countries

Press Release

May 10, 2013 /3BL Media/ - GlaxoSmithKline (GSK) today announced a new commitment to the GAVI Alliance to supply its cervical cancer vaccine as part of a new long term programme to help protect girls against cervical cancer in the world’s poorest countries. To start the programme and over the next two years, GSK will supply doses of Cervarix® (Human Papillomavirus vaccine [Types 16, 18] (Recombinant, adjuvanted, adsorbed)) to four new GAVI demonstration projects at a significantly discounted price of $4.60 per dose.

Subscribe to GAVI Alliance